Edition:
United States

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
4:00pm EDT
Change (% chg)

$-0.02 (-5.48%)
Prev Close
$0.42
Open
$0.43
Day's High
$0.44
Day's Low
$0.40
Volume
262,808
Avg. Vol
304,888
52-wk High
$2.83
52-wk Low
$0.33

Select another date:

Tue, May 15 2018

BRIEF-Onconova Therapeutics Reports Q1 Loss Per Share Of $0.34

* ONCONOVA THERAPEUTICS, INC. REPORTS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR FIRST QUARTER 2018

BRIEF-Oleg Nodelman Reports 9.99 Pct Passive Stake In Onconova Therapeutics As Of April 27, 2018

* OLEG NODELMAN REPORTS 9.99 PERCENT PASSIVE STAKE IN ONCONOVA THERAPEUTICS INC, AS OF APRIL 27, 2018 - SEC FILING Source text: (https://bit.ly/2KJY3o0) Further company coverage:

BRIEF-Onconova Therapeutics Announces Pricing Of $25 Mln Upsized Underwritten Public Offering

* ONCONOVA THERAPEUTICS ANNOUNCES PRICING OF $25.0 MILLION UPSIZED UNDERWRITTEN PUBLIC OFFERING

BRIEF-Onconova Presents Data On Dual Inhibitor Of Cdk4/6 + Ark5 At American Association For Cancer Research 2018 Annual Meeting

* ONCONOVA PRESENTS DATA ON DUAL INHIBITOR OF CDK4/6 + ARK5 AT AMERICAN ASSOCIATION FOR CANCER RESEARCH 2018 ANNUAL MEETING

BRIEF-Onconova Therapeutics Says Offering Up To 18.5 Mln Units Of Common Stock, Warrants

* ONCONOVA THERAPEUTICS - OFFERING UP TO 18.5 MILLION UNITS (UNIT CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT) Source text (https://bit.ly/2J0SqAg) Further company coverage:

BRIEF-Onconova Therapeutics Reports Full-Year 2017 Results

* ONCONOVA THERAPEUTICS, INC. REPORTS BUSINESS HIGHLIGHTS AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Onconova Therapeutics Announces License Agreement With Pint Pharma To Commercialize Rigosertib

* ONCONOVA THERAPEUTICS ANNOUNCES LICENSE AGREEMENT WITH PINT PHARMA TO COMMERCIALIZE RIGOSERTIB FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES IN LATIN AMERICA

BRIEF-683 Capital Management Reports 21.8 Pct Stake In Onconova Therapeutics

* 683 CAPITAL MANAGEMENT LLC REPORTS 21.8 PERCENT STAKE IN ONCONOVA THERAPEUTICS INC AS OF FEB 8 - SEC FILING

Select another date: